Published in Eur Respir J on March 01, 1996
The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 1.52
Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects. Thorax (1999) 1.45
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev (2010) 1.16
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Cochrane Database Syst Rev (2009) 1.14
Allergen-induced airway inflammation and its therapeutic intervention. Allergy Asthma Immunol Res (2009) 1.02
The use of sputum cell counts to evaluate asthma medications. Br J Clin Pharmacol (2001) 0.80
Inhaled corticosteroids improve lung function, airway hyper-responsiveness and airway inflammation but not symptom control in patients with mild intermittent asthma: A meta-analysis. Exp Ther Med (2017) 0.75
Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy (1977) 14.37
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet (1968) 5.08
Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax (1978) 4.77
Bird breeder's (fancier's) lung. Lancet (1966) 4.68
Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy (1977) 4.42
Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax (1992) 4.30
The perception of breathlessness in asthma. Am Rev Respir Dis (1982) 4.17
Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol (1981) 4.03
Mites and house-dust allergy. Lancet (1968) 4.01
The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85
Allergic reactions of the lungs to enzymes of Bacillus subtilis. Lancet (1969) 3.59
The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (1990) 3.40
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J (2006) 3.09
Chronic cough: eosinophilic bronchitis without asthma. Lancet (1989) 3.07
Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax (1981) 3.06
Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol (1982) 2.84
Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis (1981) 2.75
The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy (1994) 2.58
Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax (1982) 2.53
Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J (1996) 2.46
Acute asthma: emergency department management and prospective evaluation of outcome. CMAJ (1990) 2.45
Diagnostic testing in chronic urticaria and angioedema. CMAJ (1992) 2.27
Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis (1990) 2.23
High levels of Epstein-Barr virus in COPD. Eur Respir J (2008) 2.16
Late asthmatic responses. Am Rev Respir Dis (1987) 2.05
Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol (1994) 2.03
Protective effect of drugs on histamine-induced asthma. Thorax (1977) 2.02
The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol (1970) 1.97
Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med (1996) 1.97
Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol (1973) 1.96
Nonvalidated food allergy tests. CMAJ (1988) 1.94
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med (1998) 1.90
Candida albicans precipitins in respiratory disease in man. J Allergy (1968) 1.82
Canadian Thoracic Society guidelines for occupational asthma. Can Respir J (1998) 1.80
Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med (1998) 1.72
The spectrum of IgE-mediated responses to latex. JAMA (1991) 1.71
Fatal reaction to peanut antigen in almond icing. CMAJ (1988) 1.70
Standardised methodology of sputum induction and processing. Eur Respir J Suppl (2002) 1.70
Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J (2000) 1.69
Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J (1999) 1.68
Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol (1983) 1.67
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol (1983) 1.65
Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness. Eur Respir J (1993) 1.65
Exacerbations of asthma without sputum eosinophilia. Thorax (1995) 1.63
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62
Asthma, COPD and bronchitis are just components of airway disease. Eur Respir J (2006) 1.60
Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol (1979) 1.60
Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther (1979) 1.60
Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis (1979) 1.57
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55
Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax (1984) 1.55
Dimethyl ethanolamine-induced asthma. Am Rev Respir Dis (1977) 1.53
Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine. Am Rev Respir Dis (1982) 1.51
Does limb angular motion raise limb arterial pressure? Acta Physiol (Oxf) (2008) 1.49
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J (1999) 1.48
Induced sputum: validity of fluid-phase IL-5 measurement. J Allergy Clin Immunol (2000) 1.47
A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol (2000) 1.45
Airway hyperresponsiveness. Relevance of random population data to clinical usefulness. Am Rev Respir Dis (1990) 1.45
Diagnosing occupational asthma: use of induced sputum. Eur Respir J (1999) 1.42
Indirect airway challenges. Eur Respir J (2003) 1.42
Assessment and treatment of asthma. Can Fam Physician (1979) 1.41
Life-threatening asthma, urticaria, and angiooedema after ketoprofen. Lancet (1978) 1.40
Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax (1989) 1.40